Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: A pilot double-blind placebo-controlled trial

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 8, 2007, Pages 3217-3224

  Valentová, Kateřina ^a   Stejskal, David ^b   Bednář, Petr ^a   Vostálová, Jitka ^a   Číhalík, Čestmír ^c,d   Večeřová, Renata ^a   Koukalová, Dagmar ^a   Kolář, Milan ^a   Reichenbach, Richard ^e   Škňouřil, Lucyna ^e   Ulrichová, Jitka ^a   Šimánek, Vilím ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Sternberk Hospital   (Czech Republic)

^c UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^d Krajska Nemocnice T Bati as   (Czech Republic)

^e WALMARK as   (Czech Republic)

Author keywords

Adherence; AOPP; Biomarkers; Blood; Escherichia coli; Human study; Metabolites; Urine; Vaccinium macrocarpon

Indexed keywords

ESCHERICHIA COLI; VACCINIUM MACROCARPON;

EID: 34247633963     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf0636014     Document Type: Article

References (38)

1. Klein, M. A. Cranberry (Vaccinium macrocarpon) Aiton. In Encyclopedia of Dietary Supplements; Coates, P., Blackman, M. R., Cragg, G., Levine, M., Moss, J., White, J., Eds.; Marcel Dekker: New York, 2005; pp 143-149.
2. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Twelfth informational supplement; National Committee for Clinical Laboratory Standards: Wayne, PA, 2002.
3. Jepson, R. G.; Mihaljevic, L.; Craig, J. Cranberries for preventing urinary tract infections. Cochrane Database Syst. Rev. 2004, CD001321.
4. Berger, R. E. Cranberries for preventing urinary tract infections. J. Urol. 2005, 173, 1988.
5. Crews, W. D., Jr.; Harrison, D. W.; Griffin, M. L.; Addison, K.; Yount, A. M.; Giovenco, M. A.; Hazell, J. A double-blinded, placebo-controlled, randomized trial of the neuropsychologic efficacy of cranberry juice in a sample of cognitively intact older adults: Pilot study findings. J. Altern. Complement. Med. 2005, 11, 305-309.
6. McMurdo, M. E.; Bissett, L. Y.; Price, R. J.; Phillips, G.; Crombie, I. K. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial. Age Ageing 2005, 34, 256-261.
7. Super, E. A.; Kemper, K. J.; Woods, C.; Nagaraj, S. Cranberry use among pediatric nephrology patients. Ambul. Pediatr. 2005, 5, 249-252.
8. Foo, L. Y.; Lu, Y. R.; Howell, A. B.; Vorsa, N. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J. Nat. Prod. 2000, 63, 1225-1228.
9. Howell, A. B.; Reed, J. D.; Krueger, C. G.; Winterbottom, R.; Cunningham, D. G.; Leahy, M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 2005, 66, 2281-2291.
10. Leitao, D. P.; Polizello, A. C.; Ito, I. Y.; Spadaro, A. C. Antibacterial screening of anthocyanic and proanthocyanic fractions from cranberry juice. J. Med. Food. 2005, 8, 36-40.
11. Ammon, H. P. T.; Kaul, R. Crataegus. Herz-kreislauf-wirkunen von crataegusextrakten, flavonoiden und procyanidinen. Dtsch. Apothek. Z. 1994, 134, 2631-2636.
12. McGhie, T. K.; Ainge, G. D.; Barnett, L. E.; Cooney, J. M.; Jensen, D. J. Anthocyanin glycosides from berry fruit are absorbed and excreted unmetabolized by both humans and rats. J. Agric. Food Chem. 2003, 51, 4539-4548.
13. Zhang, K.; Zuo, Y. G. GC-MS determination of flavonoids and phenolic and benzoic acids in human plasma after consumption of cranberry juice. J. Agric. Food Chem. 2004, 52, 222-227.
14. Howell, A. B.; Leahy, M.; Kurowska, E.; Guthrie, N. In vivo evidence that cranberry proanthocyanidins inhibit adherence of P-fimbriated E. coli bacteria to uroepithelial cells. Fed. Am. Soc. Exp. Biol. J. 2001, 15, A284.
15. Greenberg, J. A.; Newmann, S. J.; Howell, A. B. Consumption of sweetened dried cranberries versus unsweetened raisins for inhibition of uropathogenic Escherichia coli adhesion in human urine: A pilot study. J. Altern. Complement. Med. 2005, 11, 875-878.
16. Di Martino, P.; Agniel, R.; David, K.; Templer, C.; Gaillard, J. L.; Denys, P.; Botto, H. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: A double-blind randomized placebo-controlled cross-over trial. World J. Urol. 2006, 24, 21-27.
17. Zafriri, D.; Ofek, I.; Adar, R.; Pocino, M.; Sharon, N. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob. Agents Chemother. 1989, 33, 92-98.
18. Raz, R.; Chazan, B.; Dan, M. Cranberry juice and urinary tract infection. Clin. Infect. Dis. 2004, 38, 1413-1419.
19. Gettman, M. T.; Ogan, K.; Brinkley, L. J.; Adams-Huet, B.; Pak, C. Y.; Pearle, M. S. Effect of cranberry juice consumption on urinary stone risk factors. J. Urol. 2005, 174, 590-594.
20. McHarg, T.; Rodgers, A.; Charlton, K. Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU Int. 2003, 92, 765-768.
21. Terris, M. K.; Issa, M. M.; Tacker, J. R. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001, 57, 26-29.
22. Duthie, G. G.; Kyle, J. A.; Jenkinson, A. M.; Duthie, S. J.; Baxter, G. J.; Paterson, J. R. Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice. J. Agric. Food Chem. 2005, 53, 2897-2900.
23. Aston, J. L.; Lodolce, A. E.; Shapiro, N. L. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006, 26, 1314-1319.
24. Sylvan, L.; Justice, N. P. Possible interaction between warfarin and cranberry juice. Am. Fam. Physician 2005, 72, 1000; author reply 1000.
25. Walsh, K. M. Getting to yes. J. Am. Geriatr. Soc. 2005, 53, 1072.
26. Foo, L. Y.; Lu, Y. R.; Howell, A. B.; Vorsa, N. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry 2000, 54, 173-181.
27. Christensen, G. D.; Simpson, W. A.; Younger, J. J.; Baddour, L. M.; Barrett, F. F.; Melton, D. M.; Beachey, E. H. Adherence of coagulase-negative staphylococci to plastic tissue-culture plates - A quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 1985, 22, 996-1006.
28. Ren, D. C.; Zuo, R. J.; Barrios, A. F. G.; Bedzyk, L. A.; Eldridge, G. R.; Pasmore, M. E.; Wood, T. K. Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract ursolic acid. Appl. Environ. Microbiol. 2005, 71, 4022-4034.
29. Wakimoto, N.; Nishi, J.; Sheikh, J.; Nataro, J. P.; Sarantuya, J.; Iwashita, M.; Manago, K.; Tokuda, K.; Yoshinaga, M.; Kawano, Y. Quantitative biofilm assay using a microtiter plate to screen for enteroaggregative Escherichia coli. Am. J. Trop. Med. Hyg. 2004, 71, 687-690.
30. Zheng, W.; Wang, S. Y. Antioxidant activity and phenolic compounds in selected herbs. J. Agric. Food Chem. 2001, 49, 5165-5170.
31. Psotová, J.; Večeřra, R.; Zdařilová, A.; Anzenbacherová, E.; Kosina, P.; Svobodová, A.; Hrbáč, J.; Jirovský, D.; Stiborová, M.; Lichnovský, V.; Vičar, J.; Šimáhek, V.; Ulrichová, J. Safety assesment of sanguiritrin, alkaloid fraction of Macleaya cordata, in rats. Vet. Med.-Czech. 2006, 51, 145-155.
32. Griffiths, H. R.; Moller, L.; Bartosz, G.; Bast, A.; Bertoni-Freddari, C.; Collins, A.; Cooke, M.; Coolen, S.; Haenen, G.; Hoberg, A. M.; Loft, S.; Lunec, J.; Olinski, R.; Parry, J.; Pompella, A.; Poulsen, H.; Verhagen, H.; Astley, S. B. Biomarkers. Mol. Aspects Med. 2002, 23, 101-208.
33. Kalousova, M.; Zima, T.; Tesar, V.; Dusilova-Sulkova, S.; Skrha, J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat. Res. - Fundam. Mol. Mech. Mutagen. 2005, 579, 37-46.
34. Kaneda, H.; Taguchi, J.; Ogasawara, K.; Aizawa, T.; Ohno, M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002, 162, 221-225.
35. Witko Sarsat, V.; Friedlander, M.; Capelliere Blandin, C.; Nguyen Khoa, T.; Nguyen, N. T.; Zingraff, J.; Jungers, P.; Descamps Latscha, B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49, 1304-1313.
36. Ruel, G.; Pomerleau, S.; Couture, P.; Lamarche, B.; Couillard, C. Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism 2005, 54, 856-861.
37. Duthie, S. J.; Jenkinson, A. M.; Crozier, A.; Mullen, W.; Pirie, L.; Kyle, J.; Yap, L. S.; Christen, P.; Duthie, G. G. The effects of cranberry juice consumption on antioxidant status and biomarkers relating to heart disease and cancer in healthy human volunteers. Eur. J. Nutr. 2006, 45, 113-122.
38. Ohnishi, R.; Ito, H.; Kasajima, N.; Kaneda, M.; Kariyama, R.; Kumon, H.; Hatano, T.; Yoshida, T. Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci., Biotechnol., Biochem. 2006, 70, 1681-1687.